Who Exports Caffeine from India — 471 Suppliers Behind a $107.7M Market
India's caffeine export market is supplied by 471 active exporters who collectively shipped $107.7M across 6,464 shipments. ADCOCK INGRAM LIMITED leads with a 20.7% market share, followed by SOCOMED PHARMA PRIVATE LIMITED and RONAK EXIM PRIVATE LTD. The top 5 suppliers together control 42.1% of total export value, reflecting a moderately competitive market structure.
Top Caffeine Exporters from India — Ranked by Export Value
ADCOCK INGRAM LIMITED is the leading caffeine exporter from India, holding a 20.7% share of the $107.7M market across 6,464 shipments from 471 exporters. The top 5 suppliers — ADCOCK INGRAM LIMITED, SOCOMED PHARMA PRIVATE LIMITED, RONAK EXIM PRIVATE LTD, J B CHEMICALS AND PHARMACEUTICALS LIMITED, MEDREICH LIMITED — collectively control 42.1% of total export value, indicating a competitive market. Individual shares are: ADCOCK INGRAM LIMITED (20.7%), SOCOMED PHARMA PRIVATE LIMITED (8.9%), RONAK EXIM PRIVATE LTD (4.6%), J B CHEMICALS AND PHARMACEUTICALS LIMITED (4.2%), MEDREICH LIMITED (3.7%).
Top Caffeine Exporters from India
Ranked by export value · 471 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ADCOCK INGRAM LIMITED ADCO DOL TABLETS 74400X2X20SADCO-SALTERPYN TABLETS 13598X1000SKGSADCO-SALTERPYN TABLETS 13307X1000S | $22.3M | 3 | 20.7% |
| 2 | SOCOMED PHARMA PRIVATE LIMITED 1-980 KOLD TIME TABLETFENBASE EXTRAPARACETAMOL 300MG + CAFFEINE 30MG+CPM 2M | $9.6M | 13 | 8.9% |
| 3 | RONAK EXIM PRIVATE LTD FENBASE EXTRAPARACETAMOL 300MG + CAFFEINE 30MG+CPM 2MFENBASE EXTRA IBUPROFEN PARACETAMOL CAFFEINE TABLET 930 MG | $4.9M | 6 | 4.6% |
| 4 | J B CHEMICALS AND PHARMACEUTICALS LIMITED 1-980 KOLD TIME TABLET | $4.6M | 2 | 4.2% |
| 5 | MEDREICH LIMITED 1-980 KOLD TIME TABLETSTRIMOL EXTRA ACETAMINOPHEN & CAFFEINE T | $4.0M | 5 | 3.7% |
| 6 | LABORATE PHARMACEUTICALS INDIA LTD 1-980 KOLD TIME TABLETHARMLESS MEDICINES FOR HUMAN CONSUMPTIONMR. POWER CAPSULES 50X2PARACETAMOL BP& CAFFEINE BP CAPSULE | $3.7M | 8 | 3.5% |
| 7 | BASE PHARMACY (INDIA) 1-980 KOLD TIME TABLETFENBASE EXTRAPARACETAMOL 300MG + CAFFEINE 30MG+CPM 2M | $2.8M | 2 | 2.6% |
| 8 | BASE PHARMACY INDIA 1-980 KOLD TIME TABLETFENBASE EXTRAPARACETAMOL 300MG + CAFFEINE 30MG+CPM 2M | $2.1M | 2 | 2.0% |
| 9 | PHARLINK LABS PRIVATE LIMITED SUDREK TABLETS | $1.5M | 2 | 1.4% |
| 10 | ELYSIUM PHARMACEUTICALS LTD ACETAMINOPHEN AND CAFFEINE TABLETS USPACETAMINOPHEN,ASPIRIN AND CAFFEINE TABLETS AS PER INVOICE | $1.5M | 1 | 1.4% |
| 11 | AXELIA HARMLESS MEDICINES FOR HUMAN CONSUMPTIONMR. POWER CAPSULES 50X2PARACETAMOL BP& CAFFEINE BP CAPSULE | $1.5M | 6 | 1.4% |
| 12 | KWALITY PHARMACEUTICALS LIMITED | $1.5M | 6 | 1.4% |
| 13 | RONAK EXIM PRIVATE LIMITED FENBASE EXTRAPARACETAMOL 300MG + CAFFEINE 30MG+CPM 2MFENBASE EXTRA IBUPROFEN PARACETAMOL CAFFEINE TABLET 930 MG | $1.5M | 5 | 1.4% |
| 14 | LABORATE PHARMACEUTICAL INDIA LIMITED 1-980 KOLD TIME TABLETHARMLESS MEDICINES FOR HUMAN CONSUMPTIONMR. POWER CAPSULES 50X2PARACETAMOL BP& CAFFEINE BP CAPSULE | $1.4M | 3 | 1.3% |
| 15 | BIOMATRIX HEALTHCARE PRIVATE LIMITED STRIMOL EXTRA ACETAMINOPHEN & CAFFEINE T | $1.4M | 9 | 1.3% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Caffeine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Ronak Exim Private Limited | Not Listed | Yes, as of September | No | Not verified | WHO-GMP certified for tablets, capsules, and other forms. |
| J B Chemicals & Pharmaceuticals Limited | Not Listed | Yes, as of September | No | Not verified | WHO-GMP certified for parenteral (SVP & LVP) products. |
| Elysium Pharmaceuticals Limited | Not Listed | Yes, as of March 9, | No | Not verified | WHO-GMP certified for tablets, capsules, SVP, liquid orals, dry syrup, and steri |
| Medreich Sterilab Ltd. | Not Listed | Yes, as of June 18, | No | Not verified | WHO-GMP certified for tablets, capsules, and liquid orals. |
| Laborate Pharmaceuticals India Ltd. | Not Listed | Yes, as of April 7, | No | Not verified | WHO-GMP certified for tablets, capsules, and liquid orals. |
| Kwality Pharmaceuticals Limited | Not Listed | Yes, as of April 7, | No | Not verified | WHO-GMP certified for tablets, capsules, and liquid orals. |
| BDR Pharmaceuticals International Pvt. Ltd. | Not Listed | Yes, as of September | No | Not verified | WHO-GMP certified for tablets, capsules, and SVP (lyophilized & liquid). |
| GSS Pharma Pvt. Ltd. | Not Listed | Yes, as of September | No | Not verified | WHO-GMP certified for parenteral (SVP ampoules & vials), ophthalmic preparations |
| Avik Pharmaceutical Limited | Not Listed | Yes, as of September | No | Not verified | WHO-GMP certified for bulk drug (APIs). |
TransData Nexus reviewed the regulatory standing of 9 leading Caffeine exporters from India. 0 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Caffeine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, located in Telangana, is renowned as India's bulk drug capital. The city hosts numerous pharmaceutical companies specializing in the production of Active Pharmaceutical Ingredients (APIs), including caffeine. The presence of advanced infrastructure, a skilled workforce, and supportive government policies has fostered a conducive environment for API manufacturing. Companies like Granules India, headquartered in Hyderabad, are involved in the manufacture and sale of APIs, pharmaceutical formulation intermediates, and finished dosage forms.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara belt in Gujarat is a prominent hub for pharmaceutical formulations. This region is home to a significant number of pharmaceutical units, contributing substantially to India's pharmaceutical exports. Companies in this cluster focus on producing a wide range of formulations, including those containing caffeine. For instance, Farmson Pharmaceuticals, based in Vadodara, has established a state-of-the-art facility dedicated to synthetic caffeine production, serving industries from pharmaceuticals to food and beverage.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region in Maharashtra serves as a critical export gateway for pharmaceutical products. With its proximity to major ports and well-established logistics infrastructure, this cluster facilitates the export of pharmaceuticals, including caffeine-based products, to various international markets. The region's strategic location and robust supply chain capabilities make it a preferred choice for companies aiming to expand their global footprint.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is known for its tax incentives and favorable policies that have attracted numerous pharmaceutical manufacturers. This cluster has become a significant contributor to India's pharmaceutical production, including caffeine-based formulations. The region's cost-effective manufacturing environment and supportive government initiatives have made it an attractive destination for pharmaceutical companies.
5Sourcing Recommendations
- Evaluate Supplier Capabilities: Assess the technical expertise and production capacities of suppliers in key clusters like Hyderabad and Ahmedabad-Vadodara to ensure they meet quality standards for caffeine production.
- Leverage Export Infrastructure: Utilize the logistical advantages of the Mumbai-Thane-Raigad region to streamline the export process and reduce lead times for caffeine shipments.
- Consider Cost Benefits: Explore manufacturing options in the Baddi-Nalagarh cluster to take advantage of tax incentives and potentially lower production costs for caffeine-based products.
- Monitor Regulatory Compliance: Ensure that all sourcing activities adhere to the regulatory standards set by authorities such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to maintain compliance and product quality.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Caffeine exporters from India
Adcock Ingram Pharma Private Limited — Adcock Ingram Completes New Manufacturing Facility in India
Adcock Ingram Pharma Private Limited, an affiliate of Medreich Limited, completed a new manufacturing facility in Bengaluru, India, to enhance its contract manufacturing organization (CMO) business. The facility has an annual production capacity of 750 million tablets, 75 million sachets, and 4 million bottles. - IMPACT: This expansion is expected to increase Adcock Ingram's production capacity, potentially boosting its caffeine export capabilities.
Impact: This expansion is expected to increase Adcock Ingram's production capacity, potentially boosting its caffeine export capabilities.
Adcock Ingram Holdings Limited — Natco Pharma Acquires 35.75% Stake in Adcock Ingram
Natco Pharma Limited acquired a 35.75% stake in Adcock Ingram Holdings Limited for approximately US$226 million, leading to Adcock Ingram's delisting from the Johannesburg Stock Exchange. - IMPACT: This acquisition may influence Adcock Ingram's strategic direction, potentially affecting its caffeine export operations.
Impact: This acquisition may influence Adcock Ingram's strategic direction, potentially affecting its caffeine export operations.
Adcock Ingram Holdings Limited — Natco Pharma to Acquire Significant Stake in Adcock Ingram
Natco Pharma announced plans to acquire significant stakes in Adcock Ingram, aiming to make it a privately held entity co-owned by Natco and Bidvest. - IMPACT: This strategic move could impact Adcock Ingram's operational focus, including its caffeine export activities.
Impact: This strategic move could impact Adcock Ingram's operational focus, including its caffeine export activities.
Common Questions — Caffeine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which caffeine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ADCOCK INGRAM LIMITED leads with 759 recorded shipments worth $22.3M. SOCOMED PHARMA PRIVATE LIMITED (441 shipments) and RONAK EXIM PRIVATE LTD (350 shipments) are also established high-volume exporters.
Q How many caffeine manufacturers are there in India?
India has 471 active caffeine exporters with a combined export market of $107.7M across 6,464 shipments to 122 countries. The top 5 suppliers hold 42.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for caffeine from India?
Average FOB unit price: $12.75 per unit, ranging from $0.00 to $6709.53. Average shipment value: $16.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 471 verified Indian exporters of Caffeine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 6,464 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 122 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,464 Verified Shipments
471 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists